3-T MRI-based adaptive brachytherapy for cervix cancer: Treatment technique and initial clinical outcomes

Brachytherapy

Volumn 13, Issue 4, 2014, Pages 319-325

  Kharofa, Jordan ^a   Morrow, Natalya ^a   Kelly, Tracy ^a   Rownd, Jason ^a   Paulson, Eric ^a   Rader, Janet ^a   Uyar, Denise ^a   Bradley, William ^a   Erickson, Beth ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

3 T MRI; Cervical cancer; MRI based brachytherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER SIZE; CLINICAL ARTICLE; COLOSTOMY; DIABETIC NEPHROPATHY; DISEASE SPECIFIC SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING BASED ADAPTIVE BRACHYTHERAPY; NUCLEAR MAGNETIC RESONANCE SCANNER; ORGANS AT RISK; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RETROSPECTIVE STUDY; TREATMENT PLANNING; UTERINE CERVIX CANCER; VERY ELDERLY;

3-T MRI; CERVICAL CANCER; MRI-BASED BRACHYTHERAPY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; ORGANS AT RISK; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS;

EID: 84902539256     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2014.03.001     Document Type: Article

References (19)

1. Haie-Meder C., Pötter R., Van Limbergen E., et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005, 74:235-245.
2. Pötter R., Haie-Meder C., Limbergen E.V., et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006, 78:67-77.
3. Dimopoulos J.C.A., Petrow P., Tanderup K., et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol 2012, 103:113-122.
4. Dimopoulos J.C.A., Schard G., Berger D., et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: Potential of MRI on delineation of target, pathoanatomic structures, and organs at risk. Int J Radiat Oncol Biol Phys 2006, 64:1380-1388.
5. Pötter R., Georg P., Dimopoulos J.C.A., et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011, 100:116-123.
6. Paulson E.S., Erickson B., Rownd J., et al. High-resolution, 3D T2-weighted images with isotropic voxels for MRI-based adaptive brachytherapy. Int J Radiat Oncol Biol Phys 2009, 75:S368-S369.
7. Viswanathan A.N., Beriwal S., De Los Santos J.F., et al. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: High-dose-rate brachytherapy. Brachytherapy 2012, 11:47-52.
8. Schmid M.P., Kirisits C., Nesvacil N., et al. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: A comparison of spatial dose distribution within a matched-pair analysis. Radiother Oncol 2011, 100:468-472.
9. Dimopoulos J.C.A., Schirl G., Baldinger A., et al. MRI assessment of cervical cancer for adaptive radiotherapy. Strahlenther Onkol 2009, 185:282-287.
10. Kapur T., Egger J., Damato A., et al. 3-T MR-guided brachytherapy forgynecologic malignancies. Magn Reson Imaging 2012, 30:1279-1290.
11. Viswanathan A.N., Szymonifka J., Tempany-Afdhal C.M., et al. A prospective trial of real-time magnetic resonance-guided catheter placement in interstitial gynecologic brachytherapy. Brachytherapy 2013, 12:240-247.
12. Sun W., Bhatia S.K., Jacobson G.M., et al. Target volume changes through high-dose-rate brachytherapy for cervical cancer when evaluated on high resolution (3.0 Tesla) magnetic resonance imaging. Pract Radiat Oncol 2012, 2:e101-e106.
13. Mayr N.A., Huang Z., Wang J.Z., et al. Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: Cervical cancer as a model. Int J Radiat Oncol Biol Phys 2012, 83:972-979.
14. Van de Bunt L., van der Heide U.A., Ketelaars M., et al. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression. Int J Radiat Oncol Biol Phys 2006, 64:189-196.
15. Gong Q.Y., Brunt J.N., Romaniuk C.S., et al. Contrast enhanced dynamic MRI of cervical carcinoma during radiotherapy: Early prediction of tumour regression rate. Br J Radiol 1999, 72:1177-1184.
16. Georg P., Kirisits C., Goldner G., et al. Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Radiother Oncol 2009, 91:173-180.
17. Fenkell L., Assenholt M., Nielsen S.K., et al. Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical Cancer. Int J Radiat Oncol Biol Phys 2011, 79:1572-1579.
18. Lindegaard J.C., Tanderup K. Counterpoint: Time to retire the parametrial boost. Brachytherapy 2012, 11:80-83.
19. Morrow N.V., Ahunbay E.E., Rownd J.J., et al. Cumulative dose with organ deformation for cervical cancer treated with multifraction high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2012, 84. S794-S794.